Research demonstrates the impact of optimizing drug testing panels, reducing unnecessary tests and aligning with drug use patterns.
Changes to the UDS panel aligned laboratory testing with patterns of drug use and clinical utility and standardized care within our healthcare system. Unnecessary testing was reduced; drugs removed from the panel were infrequently ordered.
No takes yet. Share an insight, caveat, or question.
Mahowald et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: